| Catalog Number |
08057532190 |
| Medical Device Problem Code |
Non Reproducible Results (4029)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/08/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The serial number of the customer's c 303 analyzer is 2115-03.The serial numbers of all other analyzers was requested, but not provided.The investigation is ongoing.
|
| |
|
Event or Problem Description
|
|
The initial reporter stated they received discrepant results for three samples collected from the same patient and tested with creatinine jaffe gen.2 on a cobas pure c 303 analytical unit and cobas integra 400 plus analyzers.The second and third samples were also tested on a c303 analyzer, a cobas c 311 analyzer, and two additional integra 400 plus analyzers at other sites.The first sample resulted in a creatinine value of 102 umol/l when tested on the customer's c 303 analyzer.The sample was repeated on the customer's integra 400 plus analyzer, resulting in a value of 39 umol/l.The second sample resulted in the following creatinine values: on the customer's c 303 analyzer = 109 umol/l and 108 umol/l on the customer's integra 400 plus analyzer = 42 umol/l and 45 umol/l on a second c303 system at a second site = 105 umol/l on a c311 analyzer at a second site = 84 umol/l and 90 umol/l with a data flag on a second integra 400 plus analyzer at a third site = 51 umol/l on a third integra 400 plus analyzer at a third site = 46 umol/l the third sample resulted in the following creatinine values: on the customer's c 303 analyzer = 120 umol/l on the customer's integra 400 plus analyzer = 52 umol/l at the customer site using a rapid test strip method (stat sensor express) = 110 umol/l on a second c303 system at a second site = 108 umol/l on a c311 analyzer at a second site = 93 umol/l on a second integra 400 plus analyzer at a third site = 48 umol/l on a third integra 400 plus analyzer at a third site = 47 umol/l.
|
| |
|
Additional Manufacturer Narrative
|
|
The patient sample's icterus index from the cobas integra 400 plus was 314 (significantly above the limit).The investigation determined the event was consistent with an icteric patient sample.Product labeling states: "limitations ¿ interference serum/plasma icterus (crej2) - no significant interference up to an i index of 5 for conjugated bilirubin and 10 for unconjugated bilirubin (approximate conjugated bilirubin concentration: 86 mol/l or 5 mg/dl; approximate unconjugated bilirubin concentration: 171 mol/l or 10 mg/dl." based on the provided information, the investigation did not identify a product problem.
|
| |
|
Search Alerts/Recalls
|